These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1283 related articles for article (PubMed ID: 12324669)
1. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Donaldson GC; Seemungal TA; Bhowmik A; Wedzicha JA Thorax; 2002 Oct; 57(10):847-52. PubMed ID: 12324669 [TBL] [Abstract][Full Text] [Related]
2. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers? Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820 [TBL] [Abstract][Full Text] [Related]
3. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715 [TBL] [Abstract][Full Text] [Related]
4. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Seemungal TA; Donaldson GC; Paul EA; Bestall JC; Jeffries DJ; Wedzicha JA Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1418-22. PubMed ID: 9603117 [TBL] [Abstract][Full Text] [Related]
5. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease. Yetkin O; Gunen H Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302 [TBL] [Abstract][Full Text] [Related]
6. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD. Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804 [TBL] [Abstract][Full Text] [Related]
7. Effect of a single exacerbation on decline in lung function in COPD. Halpin DMG; Decramer M; Celli BR; Mueller A; Metzdorf N; Tashkin DP Respir Med; 2017 Jul; 128():85-91. PubMed ID: 28610675 [TBL] [Abstract][Full Text] [Related]
8. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease. Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174 [TBL] [Abstract][Full Text] [Related]
9. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study. Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794 [TBL] [Abstract][Full Text] [Related]
10. Physical activity and the frequency of acute exacerbations in patients with chronic obstructive pulmonary disease. Schönmann M; Sievi NA; Clarenbach CF; Brack T; Brutsche M; Frey M; Irani S; Leuppi JD; Ruediger J; Senn O; Thurnheer R; Kohler M Lung; 2015 Feb; 193(1):63-70. PubMed ID: 25503750 [TBL] [Abstract][Full Text] [Related]
11. Severe exacerbations predict excess lung function decline in asthma. Bai TR; Vonk JM; Postma DS; Boezen HM Eur Respir J; 2007 Sep; 30(3):452-6. PubMed ID: 17537763 [TBL] [Abstract][Full Text] [Related]
12. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study. Kamada T; Kaneko M; Tomioka H Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791 [TBL] [Abstract][Full Text] [Related]
13. Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD. Vijayasaratha K; Stockley RA Int J Chron Obstruct Pulmon Dis; 2012; 7():789-96. PubMed ID: 23226015 [TBL] [Abstract][Full Text] [Related]
14. Effect of preceding inspiratory speed and end-inspiratory pause on forced expiratory manoeuvre in healthy subjects and chronic obstructive pulmonary disease patients. Boni E; Chiari S; Trigiani M; Gatta D; Pini L; Tantucci C Respiration; 2009; 78(3):270-7. PubMed ID: 19299889 [TBL] [Abstract][Full Text] [Related]
15. Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission. Jetmalani K; Timmins S; Brown NJ; Diba C; Berend N; Salome CM; Wen FQ; Chen P; King GG; Farah CS Int J Chron Obstruct Pulmon Dis; 2015; 10():939-45. PubMed ID: 25999709 [TBL] [Abstract][Full Text] [Related]
16. [Effect of lung transplantation on pulmonary function in 5 patients with chronic obstructive pulmonary disease]. Liu JM; Yang WL; Jiang GN; Ding JA; Wang YM; Zheng W; Zhu D; Gao BL; Jiang P; Wu W Zhonghua Jie He He Hu Xi Za Zhi; 2005 Aug; 28(8):509-12. PubMed ID: 16207394 [TBL] [Abstract][Full Text] [Related]
17. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176 [TBL] [Abstract][Full Text] [Related]
18. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878 [TBL] [Abstract][Full Text] [Related]